FC-12738
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FC-12738, covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults [Phase 1]